الصفحة الرئيسية>>Signaling Pathways>> GPCR/G protein>> Adenosine Receptor>>Tonapofylline

Tonapofylline (Synonyms: BG 9928)

رقم الكتالوجGC37815

Tonapofylline (BG 9928) هو مضاد لمستقبلات الأدينوزين A1 النشط عن طريق الفم والانتقائي مع Ki 7.4 نانومتر لمستقبل الأدينوزين البشري A1 (hA1) ، والذي يعرض انتقائية 915 ضعفًا مقابل مستقبل الأدينوزين البشري A2A والانتقائية 12 ضعفًا مقابل الأدينوزين البشري A2B مستقبل ويستخدم في التنمية لعلاج قصور القلب

Products are for research use only. Not for human use. We do not sell to patients.

Tonapofylline التركيب الكيميائي

Cas No.: 340021-17-2

الحجم السعر المخزون الكميّة
5mg
162٫00
متوفر
10mg
259٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Tonapofylline (BG 9928) is an orally active and selective adenosine A1 receptor antagonist with a Ki of 7.4 nM for human adenosine A1 receptor (hA1), which displays 915-fold selectivity versus human adenosine A2A receptor and 12-fold selectivity versus human adenosine A2B receptor and is used in development for the treatment of heart failure[1][2]. Ki: 7.4 nM (Human adenosine A1 receptor)[1]

Tonapofylline (BG 9928) (1 mg/kg; p.o., b.i.d, days 0-6) produces sustained reductions in post-Cisplatin serum creatinine and blood urea nitrogen levels, improves body weight recovery and significant attenuation of Cisplatin-induced (5.5 mg/kg) kidney pathology scores[3]. Animal Model: Female viral antigen-free Sprague-Dawley rats[3]

[1]. Kiesman WF, et al. Potent and orally bioavailable 8-bicyclo[2.2.2]octylxanthines as adenosine A1 receptor antagonists. J Med Chem. 2006 Nov 30;49(24):7119-31. [2]. Ensor CR, et al. Tonapofylline: a selective adenosine-1 receptor antagonist for the treatment of heart failure. Expert Opin Pharmacother. 2010 Oct;11(14):2405-15. [3]. Gill A, et al. Protective effect of tonapofylline (BG9928), an adenosine A1 receptor antagonist, against cisplatin-induced acute kidney injury in rats. Am J Nephrol. 2009;30(6):521-6.

مراجعات

Review for Tonapofylline

Average Rating: 5 ★★★★★ (Based on Reviews and 6 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Tonapofylline

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.